Ensifentrine; RPL 554; VMX 554

Chemical Name:

N-(2-{(2E)-9,10-dimethoxy-4-oxo-2-[(2,4,6-trimethylphenyl)imino]-6,7-dihydro-2H-pyrimido[6,1-a]isoquinolin-3(4H)-yl}ethyl)urea

SMILES Code: 

O=C(N)NCCN1C(N(CCC2=C3C=C(OC)C(OC)=C2)C3=C/C1=NC4=C(C)C=C(C)C=C4C)=O

InChi Code:

InChI=1S/C26H31N5O4/c1-15-10-16(2)24(17(3)11-15)29-23-14-20-19-13-22(35-5)21(34-4)12-18(19)6-8-30(20)26(33)31(23)9-7-28-25(27)32/h10-14H,6-9H2,1-5H3,(H3,27,28,32)/b29-23+

InChi Key:

CSOBIBXVIYAXFM-BYNJWEBRSA-N

Keyword:

1884461-72-6；CAS：1884461-72-6；CAS:1884461-72-6；RPL 554；RPL-554；RPL554；VMX 554；VMX-554；VMX554；Ensifentrine

Solubility: Soluble in DMSO

Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Description: 

Ensifentrine (RPL-554) is an inhaled, pioneering dual inhibitor of phosphodiesterase 3 (PDE3) and PDE4.

Target:  PDE3 and PDE4